HOXB7 and breast cancer: Previous studies have shown overexpression of HOXB7 to be closely associated with the clinical progression and poor prognosis of patients with breast cancer, oral squamous cell carcinomas, ovarian cancer, lung adenocarcinoma, and esophageal squamous cell cancer [33-36].